ES8600403A1 - Un procedimiento para producir un peptido que comprende un peptido de exo-senal unido operativamente a una proteina deseada - Google Patents

Un procedimiento para producir un peptido que comprende un peptido de exo-senal unido operativamente a una proteina deseada

Info

Publication number
ES8600403A1
ES8600403A1 ES537330A ES537330A ES8600403A1 ES 8600403 A1 ES8600403 A1 ES 8600403A1 ES 537330 A ES537330 A ES 537330A ES 537330 A ES537330 A ES 537330A ES 8600403 A1 ES8600403 A1 ES 8600403A1
Authority
ES
Spain
Prior art keywords
peptide
exo
dna sequence
sen
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES537330A
Other languages
English (en)
Other versions
ES537330A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of ES537330A0 publication Critical patent/ES537330A0/es
Publication of ES8600403A1 publication Critical patent/ES8600403A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/30—Signal or leader sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA PRODUCIR UN PEPTIDO QUE COMPRENDE UN PEPTIDO DE EXO-SEN/AL UNIDO OPERATIVAMENTE A UNA PROTEINA DESEADA.COMPRENDE: A) PROPORCIONAR UNA SECUENCIA DE ADN QUE CODIFICA UN PEPTIDO DE EXO-SEN/AL DE TIPO SILVESTRE QUE TIENE UNA REGION FACILITADORA CON UN RESTO DE CISTEINA, PARA FORMAR LIPOPROTEINA LIGADA A LA MEMBRANA; B) ALTERAR A LA SECUENCIA DE ADN, PARA OBTENER QUE UN PEPTIDO DE EXO-SEN/AL CODIFICADO POR LA SECUENCIA DE ADN ALTERADA QUE CONTIENE UN AMINOACIDO X DISTINTO DE LA CISTEINA EN LA REGION FACILITADORA, NO FORME LIPOPROTEINA LIGADA A LA MEMBRANA; C) UNIR LA SECUENCIA DE ADN DE (A) A LA SECUENCIA DE ADN ALTERADA QUE CODIFICA UN PEPTIDO DE EXO-SEN/AL ALTERADO PARA CONSERVAR AL AMINOACIDO X Y A LA SECUENCIA DE ADN DE (A); D) TRANSFORMAR UNA CELULA PROCARIOTICA CON UN VECTOR REPLICABLE QUE CONTIENE LAS SECUENCIAS DE ADN UNIDAS DE LAS OPERACIONES (A), (B) Y (C); Y E) DESARROLLAR A LA CELULA PROCARIOTICA TRANSFORMADA EN UN MEDIO NUTRIENTE ADECUADO, PARA OBTENER UN PEPTIDO.
ES537330A 1983-03-09 1984-11-02 Un procedimiento para producir un peptido que comprende un peptido de exo-senal unido operativamente a una proteina deseada Expired ES8600403A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/473,820 US4711844A (en) 1983-03-09 1983-03-09 Modified signal peptides

Publications (2)

Publication Number Publication Date
ES537330A0 ES537330A0 (es) 1985-09-16
ES8600403A1 true ES8600403A1 (es) 1985-09-16

Family

ID=23881126

Family Applications (2)

Application Number Title Priority Date Filing Date
ES537330A Expired ES8600403A1 (es) 1983-03-09 1984-11-02 Un procedimiento para producir un peptido que comprende un peptido de exo-senal unido operativamente a una proteina deseada
ES537329A Expired ES8507613A1 (es) 1983-03-09 1984-11-02 Un procedimiento para producir una secuencia de adn que codifica un peptido de exo-senal

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES537329A Expired ES8507613A1 (es) 1983-03-09 1984-11-02 Un procedimiento para producir una secuencia de adn que codifica un peptido de exo-senal

Country Status (9)

Country Link
US (1) US4711844A (es)
EP (1) EP0138948B1 (es)
JP (1) JPS60500701A (es)
DE (1) DE3476557D1 (es)
DK (1) DK534584D0 (es)
ES (2) ES8600403A1 (es)
FI (1) FI844375A7 (es)
IT (1) IT1199087B (es)
WO (1) WO1984003519A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411873A (en) * 1984-05-29 1995-05-02 Genencor, Inc. Process for producing heterologous polypeptides
US5840522A (en) * 1984-09-20 1998-11-24 Chiron Corporation Recombinant lectins
US4963495A (en) * 1984-10-05 1990-10-16 Genentech, Inc. Secretion of heterologous proteins
ATE78515T1 (de) * 1984-10-05 1992-08-15 Genentech Inc Dna, zellkulturen und verfahren zur sekretion von heterologen proteinen und periplasmische proteinrueckgewinnung.
DE3436818A1 (de) * 1984-10-06 1986-04-10 Hoechst Ag, 6230 Frankfurt Synthetische signalsequenz zum transport von proteinen in expressionssystemen
IT1177378B (it) * 1984-12-11 1987-08-26 Anic Spa Vettore plasmidico psm112 ad espressione in bacillus subtilis
US6084073A (en) * 1985-03-25 2000-07-04 Chiron Corporation Recombinant ricin toxin
JPH0669377B2 (ja) * 1985-11-25 1994-09-07 工業技術院長 Ｄｎａ塩基配列およびベクタ−
DE3650692T2 (de) * 1986-03-07 1999-04-22 Chiron Corp., Emeryville, Calif. Rekombinantes Ricin-Toxin
US4987070A (en) * 1987-03-04 1991-01-22 Suntory Limited Use of a 97 amino acid leader sequence from the E. coli B-galactosidase gene for the production of hanp and hptc as fusion proteins
CA1339757C (en) * 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
WO1988009821A1 (en) * 1987-06-12 1988-12-15 Massachusetts Institute Of Technology Coryneform expression and secretion system
US5171673A (en) * 1988-07-18 1992-12-15 Biotechnica International, Inc. Expression of heterologous dna using the bacillus coagulans amylase gene
US5037743A (en) * 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5284768A (en) * 1988-08-24 1994-02-08 Sanofi Signal peptide, DNA sequences coding for the latter, expression vectors carrying one of these sequences, gram-negative bacteria transformed by these vectors, and process for the periplasmic production of a polypeptide
US5028593A (en) * 1989-08-15 1991-07-02 Board Of Regents, The University Of Texas System Tuftsin analogs
WO1993007897A1 (en) * 1991-10-21 1993-04-29 Medimmune, Inc. Bacterial expression vectors containing dna encoding secretion signals of lipoproteins
US5705362A (en) * 1992-05-25 1998-01-06 Gist-Brocades, N.V. Modified signal sequences
FR2708622B1 (fr) * 1993-08-02 1997-04-18 Raymond Hamers Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides.
AU722630B2 (en) * 1997-02-14 2000-08-10 Higeta Shoyu Co., Ltd. Modified Treponema pallidum-derived antigen protein
US6017694A (en) * 1997-12-19 2000-01-25 American Cyanamid Company Methods of screening for modulators of respiratory syncytial virus matrix protein interaction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
US4351901A (en) * 1980-03-24 1982-09-28 Cetus Corporation Method for single nucleotide alteration
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
GB8308483D0 (en) * 1983-03-28 1983-05-05 Health Lab Service Board Secretion of gene products

Also Published As

Publication number Publication date
IT1199087B (it) 1988-12-30
US4711844A (en) 1987-12-08
DK534584A (da) 1984-11-09
IT8447831A0 (it) 1984-03-09
FI844375L (fi) 1984-11-07
ES537329A0 (es) 1985-09-01
FI844375A0 (fi) 1984-11-07
FI844375A7 (fi) 1984-11-07
ES537330A0 (es) 1985-09-16
EP0138948A1 (en) 1985-05-02
EP0138948B1 (en) 1989-02-01
DK534584D0 (da) 1984-11-09
DE3476557D1 (en) 1989-03-09
JPS60500701A (ja) 1985-05-16
WO1984003519A1 (en) 1984-09-13
ES8507613A1 (es) 1985-09-01
IT8447831A1 (it) 1985-09-09

Similar Documents

Publication Publication Date Title
ES8600403A1 (es) Un procedimiento para producir un peptido que comprende un peptido de exo-senal unido operativamente a una proteina deseada
ES515259A0 (es) Metodo para preparar albumina de suero humano o una proteina de fusion de la misma.
DK179684D0 (da) Immunoglobuliner og fragmenter deraf produceret af rekombinante vaertsceller, dna-sekvenser, der koder herfor, replicerbare udtrykkelsesvektorer for dna-sekvenserne, rekombinante vaertsceller transformeret med vektorerne og immunoglobuliner eller fragmenter deraf
ES8705919A1 (es) Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.
ES8600780A1 (es) Materiales y metodos de exploracion y amplificacion en celulas hospedantes eucarioticas utilizando dihidrofolato-reduc- tasa resistente a metotrexato.
DK0445646T3 (da) DNA-fragment, som koder for et polypeptid med nitrilhydrataseaktivitet, en transformant indeholdende DNA-fragmentet og en fremgangsmåde til fremstilling af amider under anvendelse af transformanten
ES8306797A1 (es) Un metodo para producir un polipeptido.
DK13788D0 (da) Fremgangsmaade til fremstilling af et polypeptid
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
DK0484787T3 (da) HCV-specifikke peptider, fremgangsmåde til opnåelse deraf og anvendelse deraf
DK0531300T3 (da) Variant-CD44-overfladeproteiner, DNA-sekvenser, som koder herfor, antistoffer mod disse proteiner samt deres anvendelse til diagnostik og terapi
DE3587422D1 (de) Fuer ein hirudinaehnliches protein kodierende dns-sequenz und verfahren zur herstellung eines solchen proteins.
KR100468977B1 (ko) 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산
DK0699753T3 (da) Transportprotein, der bevirker transport af kationiske xenobiotika og/eller farmaka, for dette kodende DNA-sekvenser og dets anvendelse
DK572284A (da) Dna, der indkoder kanintnf, vektor med det deri indsatte dna, vaert transformeret med vektoren, kanintnfpolypeptid og fremgangsmaade til fremstilling af disse
EP0546087A4 (es)
DK1205546T3 (da) Polypeptider og nucleinsyrer kodende derfor
ES2185628T3 (es) Procedimiento para preparar proteinas modificadas.
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
KR910016923A (ko) 트롬빈 결합성 물질의 제조법
DE3873273D1 (de) Verfahren zur selektiven spaltung von fusionsproteinen.
DE69838097D1 (de) Infektiöser klon für menschlichen parainfluenzavirus-typ
DK0475182T3 (da) Fremgangsmåde til proteinsyntese ved anvendelse af CKS-fusionsproteiner
DE59914155D1 (de) Neue peptidfragmente zur reinigung von proteinen
KR940021732A (ko) C형 간염 바이러스의 비구조 4 부분 단백질의 발현